Pancreatic Cancer

Comprehensive treatment for pancreatic cancer including surgery (Whipple procedure), chemotherapy, targeted therapy, and radiation therapy.

Back to All Treatments
Pancreatic Cancer

Pancreatic Cancer

Solid Tumors

Overview

Pancreatic cancer is aggressive and often diagnosed at advanced stages. Treatment requires multidisciplinary approach combining surgery, chemotherapy, and targeted therapy. Early detection is challenging but crucial for better outcomes.

When to Consult

Upon diagnosis of pancreatic cancer, jaundice, unexplained weight loss, abdominal pain, back pain, or abnormal pancreatic imaging.

What to Bring

CT/MRI scans, endoscopic ultrasound reports, CA 19-9 blood test results, biopsy reports, genetic testing results (BRCA, PALB2), and previous treatment records.

Risk Factors

Age (risk increases after 60)
Smoking (doubles the risk)
Diabetes (especially new-onset)
Family history of pancreatic cancer
Chronic pancreatitis
Obesity
Diet high in red meat and processed foods
Heavy alcohol use
Genetic syndromes (BRCA1/2, PALB2, Lynch syndrome)
Occupational exposure to chemicals
African American race
Blood type (non-O types have slightly higher risk)

Causes

Genetic mutations (KRAS, TP53, CDKN2A, SMAD4)
Chronic pancreatitis leading to inflammation
Environmental carcinogens
DNA damage accumulation
Inherited genetic mutations
Epigenetic changes
Chronic inflammation
Metabolic factors

Treatment Options

Whipple Procedure (Pancreaticoduodenectomy)

Surgical removal of head of pancreas, duodenum, gallbladder, part of bile duct, and sometimes part of stomach. Complex procedure for tumors in pancreatic head. Requires experienced surgical team.

Distal Pancreatectomy

Removal of tail and body of pancreas, often with spleen. For tumors in pancreatic body or tail. May be done laparoscopically.

Total Pancreatectomy

Removal of entire pancreas, duodenum, part of stomach, spleen, and gallbladder. Rarely performed, results in diabetes requiring insulin.

Neoadjuvant Chemotherapy

FOLFIRINOX or gemcitabine/nab-paclitaxel before surgery to shrink tumors and improve resectability. May convert borderline resectable to resectable.

Adjuvant Chemotherapy

Post-surgical chemotherapy to reduce recurrence risk. FOLFIRINOX or gemcitabine/capecitabine. Typically started 4-8 weeks after surgery.

Gemcitabine-Based Therapy

Gemcitabine alone or with nab-paclitaxel (Abraxane) for advanced disease. Standard first-line option for metastatic pancreatic cancer.

FOLFIRINOX

Combination of 5-FU, leucovorin, irinotecan, and oxaliplatin. More aggressive regimen for fit patients with good performance status.

Targeted Therapy

Olaparib (PARP inhibitor) for BRCA-mutated pancreatic cancer. Erlotinib combined with gemcitabine. Based on molecular profiling.

Radiation Therapy

External beam radiation, often combined with chemotherapy (chemoradiation). May be used before surgery (neoadjuvant) or after (adjuvant), or for locally advanced disease.

Palliative Care

Symptom management including biliary stenting for jaundice, pain management, nutritional support, and supportive care to improve quality of life.

Need Treatment?

Schedule a consultation to discuss treatment options for Pancreatic Cancer .